Researcher.Life Logo

Integrative Cancer Therapies : Impact Factor & More

eISSN: 1552-695XpISSN: 1534-7354
JournalOpen Access

Aims and Scope of Integrative Cancer Therapies

Integrative Cancer Therapies is a peer-reviewed medical journal focusing on complementary and alternative and integrative medicine in the care for and treatment of patients with cancer. Therapies like diets and lifestyle modifications, as well as experimental vaccines and chemotherapy are the subject of this journal. It was established in 2002 and is published by Sage Publications. The editor-in-chief is Keith I. Block (University of Illinois at Chicago). Less

Key Metrics

CiteScore
5.3
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.95
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Integrative Cancer Therapies

Integrative Cancer Therapies Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SAGE PUBLICATIONS INC
Language English
Frequency Bi-monthly
Article Processing ChargesUSD 2000
Publication Time15
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2002
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 15
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Integrative Cancer Therapies ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Integrative Cancer Therapies

The Experience of Shared Meditation Involving People With Cancer, Health Professionals and Third Persons: A Qualitative Focus-Group Study.
  • 1 Apr 2026
  • Integrative cancer therapies
Evaluating the Test-Retest Reliability and Measurement Error of a Sit-Stand-Power Test in Individuals Treated for Cancer.
  • 1 Apr 2026
  • Integrative cancer therapies
Comments on "Efficacy of Herbal Medicine Therapy Combined with Palliative Chemotherapy in Unresectable Advanced NSCLC: A Systematic Review and Meta-Analysis".
  • 1 Apr 2026
  • Integrative cancer therapies
Response to the Letter to the Editor Regarding “Efficacy of Herbal Medicine Therapy Combined with Palliative Chemotherapy in Unresectable Advanced NSCLC: A Systematic Review and Meta-Analysis”
  • 1 Apr 2026
  • Integrative Cancer Therapies
The Effect of a Ketogenic Diet on Cancer: Evidence From Systematic Reviews and Meta-Analyzes.
  • 1 Mar 2026
  • Integrative cancer therapies
Therapeutic Fasting as a Novel Approach to Mitigate Musculoskeletal Symptoms in Breast Cancer Patients undergoing Aromatase Inhibitor Therapy: A Feasibility Study Protocol.
  • 1 Mar 2026
  • Integrative cancer therapies
The Experience of Shared Meditation Involving People With Cancer, Health Professionals and Third Persons: A Qualitative Focus-Group Study.
  • 1 Apr 2026
  • Integrative cancer therapies
Evaluating the Test-Retest Reliability and Measurement Error of a Sit-Stand-Power Test in Individuals Treated for Cancer.
  • 1 Apr 2026
  • Integrative cancer therapies
Comments on "Efficacy of Herbal Medicine Therapy Combined with Palliative Chemotherapy in Unresectable Advanced NSCLC: A Systematic Review and Meta-Analysis".
  • 1 Apr 2026
  • Integrative cancer therapies
Response to the Letter to the Editor Regarding “Efficacy of Herbal Medicine Therapy Combined with Palliative Chemotherapy in Unresectable Advanced NSCLC: A Systematic Review and Meta-Analysis”
  • 1 Apr 2026
  • Integrative Cancer Therapies
The Effect of a Ketogenic Diet on Cancer: Evidence From Systematic Reviews and Meta-Analyzes.
  • 1 Mar 2026
  • Integrative cancer therapies
Therapeutic Fasting as a Novel Approach to Mitigate Musculoskeletal Symptoms in Breast Cancer Patients undergoing Aromatase Inhibitor Therapy: A Feasibility Study Protocol.
  • 1 Mar 2026
  • Integrative cancer therapies

FAQs on Integrative Cancer Therapies